• 9050 Citations
  • 38 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Outputs

Filter
Review article
2020

The adverse effects of androgen deprivation therapy in prostate cancer and the benefits and potential anti-oncogenic mechanisms of progressive resistance training

Lam, T., Birzniece, V., McLean, M., Gurney, H., Hayden, A. & Cheema, B. S., 13 Feb 2020, In : Sports Medicine - Open. 6, 1, p. 1-14 14 p., 13.

Research output: Contribution to journalReview article

Open Access
File
2019

Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer

Al-Mansouri, L. & Gurney, H., 1 Dec 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, 6, p. 288-295 8 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)
2017

Dose considerations for anti-cancer drugs in metastatic prostate cancer

Crumbaker, M. & Gurney, H., 1 Aug 2017, In : Prostate. 77, 11, p. 1199-1204 6 p.

Research output: Contribution to journalReview article

3 Citations (Scopus)

Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure

Rowland, A., van Dyk, M., Mangoni, A. A., Miners, J. O., McKinnon, R. A., Wiese, M. D., Rowland, A., Kichenadasse, G., Gurney, H. & Sorich, M. J., 2017, In : Expert Opinion on Drug Metabolism and Toxicology. 13, 1, p. 31-49 19 p.

Research output: Contribution to journalReview article

30 Citations (Scopus)
2015

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia

Parente, P., Gurney, H., Ng, S. & Bahre, M., 1 Sep 2015, In : Asia-Pacific Journal of Clinical Oncology. 11, 3, p. 199-207 9 p.

Research output: Contribution to journalReview article

3 Citations (Scopus)
2014

Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer

Parente, P., Parnis, F. & Gurney, H., 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 205-215 11 p.

Research output: Contribution to journalReview article

6 Citations (Scopus)

Use of targeted therapies for advanced renal cell carcinoma in the asia-pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia

Ye, D., Eto, M., Chung, J. S., Kimura, G., Chang, W. C., Chang, Y. H., Pang, S. T., Lee, J. L., Niu, Y., Gurney, H. & Uemura, H., 2014, In : Clinical Genitourinary Cancer. 12, 4, p. 225-233 9 p.

Research output: Contribution to journalReview article

15 Citations (Scopus)
2012

Evidence for therapeutic drug monitoring of targeted anticancer therapies

Gao, B., Yeap, S., Clements, A., Balakrishnar, B., Wong, M. & Gurney, H., 10 Nov 2012, In : Journal of Clinical Oncology. 30, 32, p. 4017-4025 9 p.

Research output: Contribution to journalReview article

122 Citations (Scopus)
2011

Metformin in prostate cancer: Two for the price of one

Clements, A., Gao, B., Yeap, S. H. O., Wong, M. K. Y., Ali, S. S. & Gurney, H., Dec 2011, In : Annals of Oncology. 22, 12, p. 2556-2560 5 p., mdr037.

Research output: Contribution to journalReview article

46 Citations (Scopus)

Moving towards dose individualization of tyrosine kinase inhibitors

Klümpen, H. J., Samer, C. F., Mathijssen, R. H. J., Schellens, J. H. M. & Gurney, H., Jun 2011, In : Cancer Treatment Reviews. 37, 4, p. 251-260 10 p.

Research output: Contribution to journalReview article

70 Citations (Scopus)
2010

Inhibitors of mTOR

Klümpen, H. J., Beijnen, J. H., Gurney, H. & Schellens, J. H. M., Dec 2010, In : Oncologist. 15, 12, p. 1262-1269 8 p.

Research output: Contribution to journalReview article

44 Citations (Scopus)
2008

Dose calculation of anticancer drugs

Gao, B., Klumpen, H. J. & Gurney, H., Oct 2008, In : Expert Opinion on Drug Metabolism and Toxicology. 4, 10, p. 1307-1319 13 p.

Research output: Contribution to journalReview article

30 Citations (Scopus)
2007

Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: Possible evidence of graft-versus-tumour effect

Goodwin, A., Gurney, H. & Gottlieb, D., Feb 2007, In : Internal Medicine Journal. 37, 2, p. 127-129 3 p.

Research output: Contribution to journalReview article

2 Citations (Scopus)

Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

Desai, J., Gurney, H., Pavlakis, N., Mcarthur, G. A. & Davis, I. D., Dec 2007, In : Asia-Pacific Journal of Clinical Oncology. 3, 4, p. 167-176 10 p.

Research output: Contribution to journalReview article

12 Citations (Scopus)
1996

Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative

Gurney, H., 1996, In : Journal of Clinical Oncology. 14, 9, p. 2590-2611 22 p.

Research output: Contribution to journalReview article

291 Citations (Scopus)
1993

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice - part 1

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Jan 1993, In : Annals of Oncology. 4, 1, p. 23-34 12 p.

Research output: Contribution to journalReview article

35 Citations (Scopus)

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice -part 2

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Feb 1993, In : Annals of Oncology. 4, 2, p. 103-115 13 p.

Research output: Contribution to journalReview article

36 Citations (Scopus)
1990

Hemopoietic growth factors: Their clinical role

Gurney, H. & Crowther, D., 1990, In : Drugs of the Future. 15, 6, p. 581-595 15 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)